OXYCODONE HCL
Manufacturer: Amneal Pharmaceuticals NY LLC
Score: 148.0
Oxycodone HCl extended-release tablets are an opioid agonist used for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The drug has several key clinical findings and indications, including its use in adults and opioid-tolerant pediatric patients 11 years and older. Important safety information includes warnings about addiction, abuse, and misuse, as well as contraindications such as significant respiratory depression and acute or severe bronchial asthma. The main dosing recommendations include initial dosing and titration, with dose adjustments based on individual patient needs. Special population considerations include use during pregnancy, nursing mothers, pediatric use, and geriatric use.
Addiction, abuse, and misuse, life-threatening respiratory depression, accidental ingestion, neonatal opioid withdrawal syndrome, and risks from concomitant use with benzodiazepines or other CNS depressants
Dose adjustments should be made based on individual patient needs, with careful monitoring for signs of respiratory depression, sedation, and hypotension
10 mg orally every 12 hours
Not recommended for use in pediatric patients less than 11 years of age
Not applicable
10 mg orally every 12 hours, with a minimum of 20 mg per day of oxycodone or its equivalent for at least two days immediately preceding dosing